Location History:
- Tonbridge, GB (2007)
- Hertford, DK (2009)
Company Filing History:
Years Active: 2007-2009
Title: The Innovations of David Knott
Introduction
David Knott is a notable inventor based in Hertford, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of diabetes and heart conditions. With a total of 2 patents to his name, Knott's work exemplifies the intersection of science and innovation.
Latest Patents
One of Knott's latest patents is for "Stabilized Exendin-4 compounds." This invention discloses compositions that comprise a stabilized Exendin-4 (1-39) and related compounds. The invention describes stabilized Exendin-4 agonists that include at least one modified amino acid residue, particularly at positions Gln 13, Met14, Trp25, or Asn28 of the Exendin-4 (1-39) molecule. Preferred modifications include deaminated, hydrolyzed, oxidized, or isomerized reaction products of the specified amino acid residues. This invention also relates to methods of making and using the stabilized Exendin compounds, particularly for the treatment of diabetes. Another significant patent is for "Antiarrhythmic peptides," which discloses novel peptides that have improved stability. This patent includes compositions that feature such peptides and methods of using these compositions as medicaments.
Career Highlights
David Knott is currently associated with Zealand Pharma A/S, a company known for its focus on innovative biopharmaceuticals. His work at Zealand Pharma has allowed him to contribute to groundbreaking research and development in the field of medicine.
Collaborations
Throughout his career, Knott has collaborated with several esteemed colleagues, including Bjarne Due Larsen and Kirsten Ebbehøj. These collaborations have further enriched his research and contributed to the success of his inventions.
Conclusion
David Knott's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to impact the treatment of diabetes and heart conditions, showcasing the importance of innovation in healthcare.